4-methyl-5-oxazolyl aniline | 267648-20-4

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 唑类
• 英文名称: 4-methyl-5-oxazolyl aniline
• 英文别名: 4-(4-methyl-5-oxazolyl)aniline；4-(4-Methyl-1,3-oxazol-5-yl)aniline
• CAS: 267648-20-4
• 化学式: C₁₀H₁₀N₂O
• mdl: MFCD20696654
• 分子量: 174.202
• InChiKey: DSYHPMBYDBNIHN-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.7
• 重原子数：
  13
• 可旋转键数：
  1
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.1
• 拓扑面积：
  52
• 氢给体数：
  1
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  4-methyl-5-oxazolyl aniline 在 sodium hydroxide 、 三乙胺 作用下， 以 乙醇 、 二氯甲烷 为溶剂， 生成 N-[4-(4-Methyl-oxazol-5-yl)-phenyl]-oxalamic acid
  参考文献：
  名称：

  Novel diamide-Based inhibitors of IMPDH

  摘要：

  A series of novel amide-based small molecule inhibitors of inosine monophosphate dehydrogenase is described. The synthesis and the structure-activity relationships (SARs) derived front in vitro studies are presented. (C). 2002 Elsevier Science Ltd. All rights reserved.

  DOI：

  10.1016/s0960-894x(02)00132-4
• 作为产物：
  描述：

  4-Methyl-5-(p-phenyl)-oxazol 在 palladium on activated charcoal 氢气 作用下， 以 乙醇 为溶剂， 以95%的产率得到4-methyl-5-oxazolyl aniline
  参考文献：
  名称：

  Novel diamide-Based inhibitors of IMPDH

  摘要：

  A series of novel amide-based small molecule inhibitors of inosine monophosphate dehydrogenase is described. The synthesis and the structure-activity relationships (SARs) derived front in vitro studies are presented. (C). 2002 Elsevier Science Ltd. All rights reserved.

  DOI：

  10.1016/s0960-894x(02)00132-4

文献信息

• [EN] COMPOUNDS DERIVED FROM AN AMINE NUCLEUS THAT ARE INHIBITORS OF IMPDH ENZYME<br/>[FR] COMPOSES DERIVES D'UN NOYAU AMINE INHIBITEURS DE L'ENZYME IMPDH
  申请人：BRISTOL MYERS SQUIBB CO

  公开号：WO2000025780A1

  公开（公告）日：2000-05-11

  The present invention discloses the identification of the novel inhibitors of IMPDH (inosine-5'-monophosphate dehydrogenase). The compounds and pharmaceutical compositions disclosed herein are useful in treating or preventing IMPDH mediated diseases, such as transplant rejection and autoimmune diseases.

  本发明揭示了IMPDH（鸟苷-5'-单磷酸脱氢酶）的新型抑制剂的鉴定。本文所披露的化合物和药物组合物对于治疗或预防IMPDH介导的疾病，如移植排斥和自身免疫疾病，是有用的。
• Small molecule modulators of IL-17
  申请人：LEO Pharma A/S

  公开号：US11377425B1

  公开（公告）日：2022-07-05

  The present invention relates to a compound according to formula I and pharmaceutically acceptable salts, hydrates, or solvates thereof. The invention further relates to said compounds for use in therapy, to pharmaceutical compositions comprising said compounds, to methods of treating diseases, e.g. dermal diseases, with said compounds, and to the use of said compounds in the manufacture of medicaments.

  本发明涉及一种符合式 I 的化合物 及其药学上可接受的盐、水合物或溶液。本发明还涉及用于治疗的所述化合物、包含所述化合物的药物组合物、用所述化合物治疗疾病（如皮肤病）的方法，以及在制造药物时使用所述化合物。
• EP1126843A4
  申请人：——

  公开号：EP1126843A4

  公开（公告）日：2005-06-15
• COMPOUNDS DERIVED FROM AN AMINE NUCLEUS THAT ARE INHIBITORS OF IMPDH ENZYME
  申请人：BRISTOL-MYERS SQUIBB COMPANY

  公开号：EP1126843A1

  公开（公告）日：2001-08-29
• US6399773B1
  申请人：——

  公开号：US6399773B1

  公开（公告）日：2002-06-04